Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lena Wallensteen"'
Autor:
Annelies van’t Westeinde, Leif Karlsson, Valeria Messina, Lena Wallensteen, Manuela Brösamle, Giorgio Dal Maso, Alessandro Lazzerini, Jette Kristensen, Diana Kwast, Lea Tschaidse, Matthias K Auer, Hanna F Nowotny, Luca Persani, Nicole Reisch, Svetlana Lajic
Publikováno v:
Endocrine Connections, Vol 12, Iss 4, Pp 1-14 (2023)
First-trimester prenatal treatment with glucocorticoid (GC) dexamethasone (DEX) in pregnancies at risk for classic congenital adrenal hyperplasia (CAH) is associated with ethical dilemmas. Though effective in reducing virilisation in g irls with CAH,
Externí odkaz:
https://doaj.org/article/3f270022985f4dc2a10fbe046cdd635c
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:e2481-e2487
Context The clinical use of dexamethasone (DEX) prenatally to reduce virilization of external genitalia in female fetuses with congenital adrenal hyperplasia (CAH) is efficient but still controversial. It remains challenging to prevent the excessive
Autor:
Tatja Hirvikoski, Rita Ortolano, Svetlana Lajic, Valeria Messina, Antonio Balsamo, Anna Nordenström, Lena Wallensteen, Sophia Vissani, Leif Karlsson
Publikováno v:
Endocrine
Purpose Patients with classic congenital adrenal hyperplasia (CAH) are treated postnatally with life-long glucocorticoid (GC) replacement therapy. Although prolonged exposure to GCs may have a negative impact on behaviour, few studies have studied th
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Background Prenatal treatment with dexamethasone (DEX) reduces virilization in girls with congenital adrenal hyperplasia (CAH). The treatment is effective but may result in long-lasting adverse effects. In this study we explore the effects of DEX on
Autor:
Tatja Hirvikoski, Malin Thomsen Sandberg, Anton Gezelius, Lena Wallensteen, Valeria Messina, Leif Karlsson, Anna Nordenström, Svetlana Lajic
Publikováno v:
Hormones and behavior. 98
Prenatal dexamethasone (DEX) treatment in congenital adrenal hyperplasia (CAH) is effective in reducing virilization in affected girls, but potential long-term adverse effects are largely unknown. In this report we intended to explore potential side
Autor:
Lena Wallensteen, Malin Thomsen Sandberg, Svetlana Lajic, Anna Nordenström, Tatja Hirvikoski, Marius Zimmermann, Anton Gezelius
Publikováno v:
The Journal of clinical endocrinology and metabolism. 101(10)
Dexamethasone (DEX) is used to prevent virilization in female fetuses at risk of congenital adrenal hyperplasia (CAH). Given that treatment has to be started before the genotype is known, 7 out of 8 fetuses will be exposed to DEX without benefit.To e
Autor:
Tatja Hirvikoski, Marius Zimmermann, Lena Wallensteen, Anna Nordenström, Anton Gezelius, Svetlana Lajic, Malin Thomsen Sandberg
Publikováno v:
Hormones and behavior. 85
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the authors due to technical errors that have called into question
Autor:
Malin Thomsen Sandberg, Svetlana Lajic, Tatja Hirvikoski, Marius Zimmermann, Anna Nordenström, Anton Gezelius, Lena Wallensteen
Publikováno v:
Hormones and Behavior. 103:140
Autor:
Urban Fläring, Rafael T. Krmar, Lena Wallensteen, Per-Arne Lönnqvist, Jan F. Svensson, Ingimar Ingolfsson, Björn Frenckner, Jan Kowalski, Shayarina Stigzelius
Publikováno v:
BMC Pediatrics, Vol 11, Iss 1, p 61 (2011)
BMC Pediatrics
BMC Pediatrics
Background Hyponatremia is the most frequent electrolyte abnormality observed in post-operative pediatric patients receiving intravenous maintenance fluid therapy. If plasma sodium concentration (p-Na+) declines to levels below 125 mmol/L in < 48 h,